Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program

por Bussel, James B., Arnold, Donald M., Boxer, Michael A., Cooper, Nichola, Mayer, Jiri, Zayed, Hany, Tong, Sandra, Duliege, Anne‐Marie
Publicado 2019

Fostamatinib is an effective second‐line therapy in patients with immune thrombocytopenia

por Boccia, Ralph, Cooper, Nichola, Ghanima, Waleed, Boxer, Michael A, Hill, Quentin A., Sholzberg, Michelle, Tarantino, Michael D., Todd, Leslie K., Tong, Sandra, Bussel, James B.
Publicado 2020

Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open‐label study

por Kuter, David J., Rogers, Kerry A., Boxer, Michael A., Choi, Michael, Agajanian, Richy, Arnold, Donald M., Broome, Catherine M., Field, Joshua J., Murakhovskaya, Irina, Numerof, Robert, Tong, Sandra
Publicado 2022